Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00280163 · ClinicalTrials.gov registry record
Genomics and Postoperative Atrial Fibrillation
A clinical trial of Postoperative Atrial Fibrillation, Genomics, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 336
- Enrollment target
- 1
- Study location
NCT00280163 is a study of Postoperative Atrial Fibrillation, Genomics that has completed, run by University of Pittsburgh. The registered enrollment target is 336 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00280163, a study of Postoperative Atrial Fibrillation, Genomics, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 336 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aware, the DNA (Deoxyribonucleic acid) is a chemical in our body that carries the genetic information. There are common but very small variations (polymorphisms) that occur in DNA. We would like to find out if these common variations put a person at increased risk for developing complications- especially rapid irregular heart beat after the CABG operation.
Conditions Studied
Study Locations (1)
Pennsylvania
- UPMC PUH - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2005-11 |
| Est. Completion | 2011-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00280163
The ClinicalTrials.gov registry entry for NCT00280163 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 336 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Atrial Fibrillation, Genomics appearing as the primary indexed condition, and to 0 interventions.
NCT00280163 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00280163 about?
NCT00280163 is a clinical study titled "Genomics and Postoperative Atrial Fibrillation". This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aware, the DNA (Deoxyribonucleic acid) is a chemical in our body that carries the genetic information. There are c...
What is the current status of trial NCT00280163?
This trial is currently completed. The enrollment target is 336 participants. The study started on 2005-11. Estimated completion is 2011-02.
What conditions does trial NCT00280163 study?
This clinical trial studies the following conditions: Postoperative Atrial Fibrillation, Genomics.
Who is sponsoring clinical trial NCT00280163?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00280163 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.